Sign in

CIK 0001807120 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Design Therapeutics, Inc.

Sign in to watch
Ticker
DSGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
823929248
Phone
858-293-4900
Business address
6005 HIDDEN VALLEY ROAD, SUITE 110, CARLSBAD, CA, 92011
  1. S-3 Offering Registration Statement
  2. 424B5 Offering Prospectus
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  6. SCHEDULE 13G Stake Statement of Beneficial Ownership
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 8-K Event Shareholder vote results
  16. SCHEDULE 13G Stake Statement of Beneficial Ownership
  17. 8-K Event Other events
  18. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  19. 10-Q Report Quarterly Report
  20. 8-K Event Results of operations · Regulation FD disclosure

Page 1 of 14 · 268 filings